Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diatrizoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diatrizoic Acid SCHEMBL720469 | 0.99 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL1685085 | 0.99 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL107036 | 0.99 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL2501947 | 0.97 | SMN1; SMN2 (0.97) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL3060866 | 0.92 | SMN1; SMN2 (0.83) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL4334352 | 0.92 | SMN1; SMN2 (0.87) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL29488709 | 0.91 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL180546 | 0.91 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL48785 | 0.91 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iodamide SCHEMBL9808844 | 0.89 | SMN1; SMN2 (0.78) | SMN1; SMN2KDM4ELMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114739966-A | Tumor screening kit based on blood analysis | 上海翊嘉生物科技有限公司 | 2022-07-12 | — | — | CN | claimed |
| JP-7309782-A | — | — | None | — | — | JP | disclosed |
| US-20250058078-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | ANCORA HEART, INC. | 2025-02-20 | — | — | US | disclosed |
| US-11980722-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| CN-114739966-A | Tumor screening kit based on blood analysis | 上海翊嘉生物科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-20220152348-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | ANCORA HEART, INC. | 2022-05-19 | — | — | US | disclosed |
| US-11202883-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2021-12-21 | — | — | US | disclosed |
| WO-2021162110-A1 | GEL DOSIMETER FOR MEASURING RADIATION DOSES | 学校法人北里研究所 | 2021-08-19 | — | — | WO | disclosed |
| US-20200147343-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | GUIDED DELIVERY SYSTEMS INC. | 2020-05-14 | — | — | US | disclosed |
| US-10625046-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| WO-2008057534-A2 | METHODS AND COMPOSITIONS FOR ORGAN PROTECTION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2007127958-A2 | DETECTION AND IMAGING OF TARGET TISSUE | BARNES-JEWISH HOSPITAL (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070258908-A1 | Detection and imaging of target tissue | KEREOS, INC. | 2007-11-08 | — | — | US | disclosed |
| EP-1776118-A2 | IRON CHELATORS FOR TREATING RADIOCONTRAST-ASSOCIATED RENAL DYSFUNCTION | Shiva Biomedical, LLC (US) | 2007-04-25 | — | — | EP | disclosed |
| US-20060127315-A1 | Methods of treating humans undergoing injection of a contrast agent | SHIVA BIOMEDICAL, L.L.C. (US) | 2006-06-15 | — | — | US | disclosed |
| WO-2006017650-A2 | IRON CHELATORS FOR TREATING RADIOCONTRAST-ASSOCIATED RENAL DYSFUNCTION | SHIVA BIOMEDICAL, LLC (US) | 2006-02-16 | — | — | WO | disclosed |
| JP-H07309782-A | CONTRAST MEDIUM | OGAWA TAKAHIRO | 1995-11-28 | — | — | JP | disclosed |
| US-5346696-A | Recombinent Interferon | KOREA GREEN CROSS CORPORATION (KR) | 1994-09-13 | — | — | US | disclosed |
| EP-0544878-A1 | ASIALOGLYCOPROTEIN-CONJUGATED MEDICINAL AGENT | COREA GREEN CROSS CORPORATION (KR) | 1993-06-09 | — | — | EP | disclosed |
| WO-1992022310-A1 | ASIALOGLYCOPROTEIN-CONJUGATED MEDICINAL AGENT | LIVER RESEARCH FOUNDATION OF KOREA (KR) | 1992-12-23 | — | — | WO | disclosed |